IHE icon

iShares US Pharmaceuticals ETF
IHE

Overview Fund Activity

113 hedge funds and large institutions have $118M invested in iShares US Pharmaceuticals ETF in 2022 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 27 increasing their positions, 30 reducing their positions, and 19 closing their positions.

Holders
113
Holders Change
-12
Holders Change %
-9.6%
% of All Funds
1.95%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
27
Reduced
30
Closed
19
Calls
$441K
Puts
$206K
Net Calls
+$235K
Net Calls Change
+$235K

Top Buyers

1
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$5.85M
2
Citadel Advisors
2
Citadel Advisors
Florida
$3.04M
3
PGFC
3
Peapack-Gladstone Financial Corp
New Jersey
$2.89M
4
Fisher Asset Management
4
Fisher Asset Management
Washington
$3.71M
5
UBS Group
5
UBS Group
Switzerland
$4.62M

Top Sellers

1
EE
1
EWG Elevate
California
$0
2
RWP
2
RWA Wealth Partners
Massachusetts
$0
3
Goldman Sachs
3
Goldman Sachs
New York
$1.42M
4
AWS
4
Atria Wealth Solutions
New York
$740K
5
TRCT
5
Tower Research Capital (TRC)
New York
$706K
Name Market Value Shares Shares
Change 		Shares
Change %
WI
126
Wintrust Investments
Illinois
– – -1,070 Closed
MFG
127
Magnus Financial Group
New York
– – -1,065 Closed
CF
128
Centaurus Financial
California
– – -1,030 Closed
MPCG
129
Matrix Private Capital Group
New York
– – -565 Closed
JPLA
130
Joseph P. Lucia & Associates
New York
– – -450 Closed
VVP
131
Venture Visionary Partners
Ohio
– – -275 Closed
RG
132
Retirement Group
California
– – -4 Closed
HNB
133
Huntington National Bank
Ohio
– – – –
2 3 4 5
6